div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=document6-ylldmm-e-n-k-ipek-e-af-ulusov-fr-hatem-e-the-evaluation-of-the-clinicalhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: · 6 Ylldmm E N- K ipek E AF Ulusov FR- Hatem E The evaluation of the clinical utility of urocortin I and adrenomedullin versus proBNP in systolic heart Anatol CardiaL 2017 loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsusreader034viewer20220502165f624e8dfa02e8661851de5fhtml5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=document6-ylldmm-e-n-k-ipek-e-af-ulusov-fr-hatem-e-the-evaluation-of-the-clinicalhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: · 6 Ylldmm E N- K ipek E AF Ulusov FR- Hatem E The evaluation of the clinical utility of urocortin I and adrenomedullin versus proBNP in systolic heart Anatol CardiaL 2017 loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsusreader034viewer20220502165f624e8dfa02e8661851de5fhtml5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=document6-ylldmm-e-n-k-ipek-e-af-ulusov-fr-hatem-e-the-evaluation-of-the-clinicalhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: · 6 Ylldmm E N- K ipek E AF Ulusov FR- Hatem E The evaluation of the clinical utility of urocortin I and adrenomedullin versus proBNP in systolic heart Anatol CardiaL 2017 loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...